Home NDC 68788-9111-01 NDC 68788-9111-01 - Ibuprofen This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 68788-9111
Requested NDC 68788-9111-01
Package NDCs from labels 68788-9111-2, 68788-9111-7, 68788-9111-3, 68788-9111-5, 68788-9111-6, 68788-9111-9, 68788-9111-1, 68788-9111-8, 68788-9111-01
Manufacturer Preferred Pharmaceuticals, Inc.
Effective date 2026-05-13
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type IBU ™ Tablets Preferred Pharmaceuticals, Inc. 2026-05-13 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68788-9111 IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 15 Current NDC, Legacy NDC, 8 package rows 20240526_72ec2491-924d-460f-9510-62d624d54b59.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Ibuprofen ACTIVE INGREDIENT WK2XYI10QM IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 Ibuprofen ACTIVE MOIETY WK2XYI10QM IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 carnauba wax INACTIVE INGREDIENT R12CBM0EIZ IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 croscarmellose sodium INACTIVE INGREDIENT M28OL1HH48 IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 magnesium stearate INACTIVE INGREDIENT 70097M6I30 IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 polydextrose INACTIVE INGREDIENT VH2XOU12IE IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 Polyethylene Glycols INACTIVE INGREDIENT 3WJQ0SDW1A IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP IBUPROFEN TABLET [PREFERRED PHARMACEUTICALS, INC.] 5
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 4 of 193 · 3,850 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join HERA SILKYSTAY FOUNDATION 17C2 TITANIUM DIOXIDE Amorepacific Corporation 5eb338c7-e99c-887d-e063-6394a90a977c 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 17N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb363fe-c2b2-9381-e063-6294a90ad038 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 17W1 TITANIUM DIOXIDE Amorepacific Corporation 5eb39387-7f6b-ce78-e063-6394a90a15ae 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 21C2 TITANIUM DIOXIDE Amorepacific Corporation 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 21N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 22N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb415b3-b1ba-42b8-e063-6394a90a90d7 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 21W1 TITANIUM DIOXIDE Amorepacific Corporation 5eb42062-f298-5186-e063-6294a90ab043 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 23C2 TITANIUM DIOXIDE Amorepacific Corporation 5eb44e1b-b24b-6c83-e063-6394a90a4b52 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 23W1 TITANIUM DIOXIDE Amorepacific Corporation 5eb468db-3c38-922d-e063-6294a90adef8 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 24N1 TITANIUM DIOXIDE Amorepacific Corporation 5eb4b8ca-eced-b7ff-e063-6394a90aaefe 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 24O1 TITANIUM DIOXIDE Amorepacific Corporation 5eb4f87a-b4dc-1aa5-e063-6294a90a2ec4 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 25W1 TITANIUM DIOXIDE Amorepacific Corporation 5eb50784-444e-3bf3-e063-6294a90aa618 2026-10-25 Warnings Exact identifier unii: 15FIX9V2JP Ibuprofen IBUPROFEN REMEDYREPACK INC. 404df13d-4ada-4324-9eed-e21f5d5043a4 2026-10-23 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 197807 unii: WK2XYI10QM Ibuprofen and famotidine IBUPROFEN AND FAMOTIDINE Ascend Laboratories, LLC 4493d4cd-ca8e-4b0a-9b65-b75e55bf8b9e 2026-10-23 Boxed warning, Warnings, Adverse reactions Exact identifier unii: WK2XYI10QM Ibuprofen IBUPROFEN PD-Rx Pharmaceuticals, Inc. 0fa4cd66-66ad-4ec9-b38c-6b5840df39df 2026-10-22 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 197805 unii: WK2XYI10QM CHILDRENS IBUPROFEN IBUPROFEN Amazon.com Services LLC b857c13a-b1e2-4f6a-bb66-4bac431cfa33 2026-10-22 Warnings Exact identifier unii: WK2XYI10QM KARYNG Complete SPF Sunscreen Medium/Dark SUNSCREEN Karyng LLC 335eee1e-ef1c-41da-e063-6294a90ac273 2026-10-20 Warnings Exact identifier unii: 15FIX9V2JP Ibuprofen IBUPROFEN Redpharm Drug 5e426629-8733-366a-e063-6394a90a8e39 2026-10-20 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 197807 unii: WK2XYI10QM Ibuprofen IBUPROFEN AAA Pharmaceutical, Inc. 4aba1bf2-8146-04fa-e063-6294a90a8a21 2026-10-20 Warnings Exact identifier unii: WK2XYI10QM childrens ibuprofen IBUPROFEN Amazon.com Services LLC 760151df-1f53-458c-9f9f-321c62de96d3 2026-10-19 Warnings Exact identifier unii: WK2XYI10QM
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.